Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Alkem Laboratories Ltd.Alkem Laboratories Ltd.
VS
Glenmark PharmaceuticalsGlenmark Pharmaceuticals
Alkem Laboratories Ltd.

Alkem Laboratories Ltd.

Lower Parel, Alkem House , Mumbai, IN, 400013

Last Update: 01/04/2026

View Profile
Between 750 and 799
http://www.alkemlabs.com
775/1000Fair

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It wa...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:15,609
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

Glenmark House, B.D.Sawant Marg,, Chakala, Andheri (East), Mumbai, Maharashtra, IN, 400099

Last Update: 12/09/2026

View Profile
650/1000Weak

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our jou...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:14,777
Subsidiaries:0
12-month incidents
1
Known data breaches
0
Attack type number
1

Compliance Ranges Comparison

Based On Specific Ai Models Category
Alkem Laboratories Ltd.

Alkem Laboratories Ltd.

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Alkem Laboratories Ltd. in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Glenmark Pharmaceuticals has 2.91% fewer incidents than the average of all companies with at least one recorded incident.

Incidents

Incident History - Alkem Laboratories Ltd. (X = Date, Y = Severity)

Alkem Laboratories Ltd. cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Glenmark Pharmaceuticals (X = Date, Y = Severity)

Glenmark Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Alkem Laboratories Ltd.

Alkem Laboratories Ltd.

Incidents
No explicit notable incidents reported.
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

Incidents
🔒 Incident : Ransomware
KOPGLE1777473227

FAQ

Between Alkem Laboratories Ltd. company and Glenmark Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between Alkem Laboratories Ltd. company and Glenmark Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between Alkem Laboratories Ltd. company and Glenmark Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between Alkem Laboratories Ltd. company and Glenmark Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between Alkem Laboratories Ltd. company and Glenmark Pharmaceuticals company, which one has experienced at least one data breach ?
Between Alkem Laboratories Ltd. company and Glenmark Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between Alkem Laboratories Ltd. company and Glenmark Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between Alkem Laboratories Ltd. company and Glenmark Pharmaceuticals company, which one holds the most compliance certifications ?
Between Alkem Laboratories Ltd. company and Glenmark Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between Alkem Laboratories Ltd. company and Glenmark Pharmaceuticals company, which one has the most subsidiaries ?
Between Alkem Laboratories Ltd. company and Glenmark Pharmaceuticals company, which one has the largest number of employees ?
Between Alkem Laboratories Ltd. and Glenmark Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between Alkem Laboratories Ltd. and Glenmark Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Alkem Laboratories Ltd. or Glenmark Pharmaceuticals ?
Which company is PCI DSS compliant - Alkem Laboratories Ltd. or Glenmark Pharmaceuticals ?
Between Alkem Laboratories Ltd. and Glenmark Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between Alkem Laboratories Ltd. and Glenmark Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-90461
SUMMARY

OpenStack Ironic through 38.0.0 may send a username and password to an unexpected remote host when Image Service is configured for HTTP(S) Basic Authentication.

PUBLISHED
Date2026-09-11
UPDATED
Date2026-09-11
RISK INFORMATION (Score: 6.3)
CVSS3
Base Score: 6.3
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:N/A:N
IMPACT SCORE
4
EXPLOITABILITY
1.8
CVE-2026-90460
SUMMARY

An issue was discovered in OpenStack Keystone before 29.0.3. Tokens obtained via delegated authentication methods (EC2 credentials, application credentials, OAuth1 access tokens, and trusts) are not blocked from creating, modifying, or deleting credentials via the /v3/credentials API. EC2-derived tokens can additionally read credential blobs, exposing TOTP MFA seeds and other secrets. Also, PATCH /v3/credentials does not validate the requested post-update project_id, allowing any delegated token to move a credential to an unauthorized project. All Keystone deployments using delegated authentication are affected.

PUBLISHED
Date2026-09-11
UPDATED
Date2026-09-11
RISK INFORMATION (Score: )
CVSS4
Base Score: 7.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-90457
SUMMARY

The administrative password is hashed using a comparatively weak, fast algorithm for the credential store backing one authentication path, and the file containing that hash is written with permissions allowing it to be read by any local user. This is inconsistent with a separate, stronger hashing algorithm used for the same password on another authentication path. A party able to read this file, including a local user or a party with access to a configuration backup, could feasibly recover the underlying password through offline computation, compromising the administrative credential across every path that accepts it.

PUBLISHED
Date2026-09-11
UPDATED
Date2026-09-11
RISK INFORMATION (Score: )
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-90456
SUMMARY

An example environment-configuration file for a bundled inventory-management component ships with a fixed, publicly-known administrative password. A deployment that copies this example file into active configuration without running the setup routine that regenerates credentials will expose that component's administrative interface to anyone aware of the default value.

PUBLISHED
Date2026-09-11
UPDATED
Date2026-09-11
RISK INFORMATION (Score: )
CVSS4
Base Score: 9.2
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-90455
SUMMARY

A prior update that raised a bundled HTTP client library to a version remediating known vulnerabilities was later reverted, reintroducing the earlier, vulnerable version into a log-processing component. The only code path in that component using the library issues a request to a single fixed, trusted vendor URL at initialization and does not process attacker-controlled input through the library, limiting practical exploitability of the reintroduced version in this context.

PUBLISHED
Date2026-09-11
UPDATED
Date2026-09-11
RISK INFORMATION (Score: )
CVSS4
Base Score: 6.3
Complexity: HIGH
CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA